Invesco
NUTX

Invesco’s Nutex Health NUTX Stock Holding History

Invesco’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$884K Buy
5,173
+967
+23% +$123K ﹤0.01% 2983
2026
Q1 		$400K Sell
4,206
-686
-14% -$84.1K ﹤0.01% 3243
2025
Q4 		$805K Buy
4,892
+2,874
+142% +$381K ﹤0.01% 3001
2025
Q3 		$208K Sell
2,018
-52
-3% -$5.1K ﹤0.01% 3554
2025
Q2 		$258K Buy
+2,070
New +$267K ﹤0.01% 3429
2023
Q4 		– Sell
-72
Closed -$2.19K – 3874
2023
Q3 		$2.19K Hold
72
– – ﹤0.01% 3868
2023
Q2 		$4.56K Sell
72
-440
-86% -$37.7K ﹤0.01% 3858
2023
Q1 		$77.6K Buy
512
+14
+3% +$2.83K ﹤0.01% 3724
2022
Q4 		$142K Buy
498
+385
+341% +$73.9K ﹤0.01% 3771
2022
Q3 		$25K Buy
113
+13
+13% +$5.51K ﹤0.01% 3962
2022
Q2 		$48K Buy
+100
New +$118K ﹤0.01% 3971

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Invesco's NUTX Position: Q2 2026 in Review

Invesco increased its Nutex Health (NUTX) stake by 23% in Q2 2026, buying an estimated $123K and bringing the position to 5,173 shares worth $884K. The position accounts for ﹤0.01% of the portfolio, ranked #2983.

Invesco first reported a position in NUTX in Q2 2022 and has held it in 11 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Invesco held 5,173 shares of Nutex Health worth $884K as of Q2 2026.
  • Invesco bought 967 Nutex Health shares in Q2 2026, an estimated $123K.
  • Nutex Health made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2983 holding.
  • Invesco first reported a position in Nutex Health in Q2 2022 and has held it in 11 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.